SHANNON JACKSON-WILLIAMS: Open Payments
NPI 1811323645 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,524 in 136 payments from 9 companies in 2025. Trend: 2023 $1,758 · 2024 $2,523 · 2025 $2,524
Food & beverage: $2,399Education: $125
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $642 |
| E.R. Squibb & Sons, L.L.C. | 20 | $431 |
| Neurocrine BioSciences, Inc. | 25 | $320 |
| Alkermes, Inc. | 18 | $290 |
| Janssen Pharmaceuticals, Inc | 20 | $277 |
| ABBVIE INC. | 24 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $243 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Amgen Inc. | 1 | $17 |
Products named: AUSTEDO XR, COBENFY, INGREZZA, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, ARISTADA, LYBALVI.
Industry payments across LA — which companies pay providers there.
